» Articles » PMID: 33507700

Association Between Genetic Polymorphisms of MiR-1307, MiR- 1269, MiR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women

Overview
Specialty Oncology
Date 2021 Jan 28
PMID 33507700
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: MicroRNAs (miRNAs) play an essential role in the susceptibility and development of cancer cells.

Objective: Examining the dependency of breast cancer risk with genetic polymorphisms of miR-1307, miR-1269, and miR-3117 in a sample of Iranian women (southeast region).

Methods: The case-control study consisted of 520 individuals (260 diagnosed BC patients, 260 healthy individuals). The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for genotyping of miR-1307 rs7911488, miR-1269 rs73239138, and miR-3117 (rs4655646 and rs7512692) polymorphisms.

Results And Conclusion: This study provided evidence that miR-1307 rs7911488 polymorphism significantly reduced the risk of BC in heterozygous AG genotype, as well as dominant (AG+GG) genotype and G allele. A significant correlation was found between dominant (AA+AG) genotype, the A allele and protection against BC due to miR-1269 rs73239138 in the sample of study. In contrast, our findings suggested that AG genotype and G allele of miR-3117 rs4655646 polymorphism could increase BC's susceptibility among the southeastern Iranian females. The miR-3117 rs7512692 variant also increased the risk of BC in codominant, dominant and recessive models, as well as the T allele. The possible dependency of miR-1307, miR-1269, and miR-3117 variants with patients' clinicopathological characteristics and BC was also studied. It was concluded that there is a correlation between miR-3117 rs7512692 variant and tumor grade (p=0.031); also, a correlation between miR-1269 rs73239138 variant and progesterone receptor status (p=0.006). The current investigation revealed that miR-1307, miR-1269, and miR-3117 polymorphisms might play a crucial role in the Iranian population's vulnerability to BC.<br />.

Citing Articles

The Reticulon-4 3-bp Deletion/Insertion Polymorphism Is Associated with Structural mRNA Changes and the Risk of Breast Cancer: A Population-Based Case-Control Study with Bioinformatics Analysis.

Pourzand P, Tabasi F, Fayazbakhsh F, Sarhadi S, Bahari G, Mohammadi M Life (Basel). 2023; 13(7).

PMID: 37511924 PMC: 10381770. DOI: 10.3390/life13071549.


miR-1269a and miR-1269b: Emerging Carcinogenic Genes of the miR-1269 Family.

Xie Z, Zhong C, Duan S Front Cell Dev Biol. 2022; 10:809132.

PMID: 35252180 PMC: 8894702. DOI: 10.3389/fcell.2022.809132.


Signatures of genetic variation in human microRNAs point to processes of positive selection and population-specific disease risks.

Villegas-Miron P, Gallego A, Bertranpetit J, Laayouni H, Espinosa-Parrilla Y Hum Genet. 2022; 141(10):1673-1693.

PMID: 35249174 PMC: 9522702. DOI: 10.1007/s00439-021-02423-8.


Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells.

Hu Y, Ma Y, Luo G, Liao W, Zhang S, Li G Evid Based Complement Alternat Med. 2021; 2021:3088723.

PMID: 34512774 PMC: 8429006. DOI: 10.1155/2021/3088723.

References
1.
Garcia-Donas J, Beuselinck B, Inglada-Perez L, Grana O, Schoffski P, Wozniak A . Deep sequencing reveals microRNAs predictive of antiangiogenic drug response. JCI Insight. 2016; 1(10):e86051. PMC: 5033860. DOI: 10.1172/jci.insight.86051. View

2.
Jayasekara H, MacInnis R, Hodge A, Room R, Milne R, Hopper J . Is breast cancer risk associated with alcohol intake before first full-term pregnancy?. Cancer Causes Control. 2016; 27(9):1167-74. DOI: 10.1007/s10552-016-0789-3. View

3.
Meijer H, Kong Y, Lu W, Wilczynska A, Spriggs R, Robinson S . Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science. 2013; 340(6128):82-5. DOI: 10.1126/science.1231197. View

4.
Eckhardt B, Francis P, Parker B, Anderson R . Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov. 2012; 11(6):479-97. DOI: 10.1038/nrd2372. View

5.
Moazeni-Roodi A, Ghavami S, Hashemi M . Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies. Microrna. 2018; 8(2):94-100. DOI: 10.2174/2211536608666181204110508. View